Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 19, 2020
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has commenced registered offerings of $1.5 billion of common stock, par value $1.00 per share, and $1.5 billion of depositary...
-
May 7, 2020- As reported, revenues of $4.253 billion increased 1.4 percent
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.253 billion for the second fiscal quarter ended March 31, 2020....
-
May 5, 2020
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Bank of America Securities Virtual Healthcare Conference...
-
Apr 28, 2020
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.79 per common share, payable on June 30, 2020 to holders of record on June 9, 2020....
-
Apr 27, 2020Recalls for BodyGuard® Infusion Pumps and Certain Lots of CMEAmerica BodyGuard® Microsets Designated as Class I Recalls
CME America, a wholly owned subsidiary of BD (Becton, Dickinson and Company), a leading global medical technology company, today issued the following update regarding two previously announced...
-
Apr 13, 2020New Test Uses BD MAX™ System to Augment Supply from Existing Collaborations; Test Results in Under Three Hours
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use...
-
Apr 6, 2020
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2020 earnings conference call on Thursday, May 7, 2020, at 8:00 a.m....
-
Apr 3, 2020New Test Immediately Available to Increase Capacity of Rapid, On-Site Testing of COVID-19 at Hospitals Across the U.S.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc., a molecular diagnostics company, today announced that the U.S. Food and Drug...
-
Mar 31, 2020Point-of-care blood test detects evidence of present or past exposure in 15 minutes
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, today announced...
-
Mar 16, 2020New Diagnostics Have Potential to Increase Capacity of COVID-19 Testing in U.S. by Thousands of Tests Per Day
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc, a molecular diagnostics company, today announced that the companies have submitted...
-
Mar 13, 2020
BD (Becton, Dickinson and Company) (NYSE: BDX), today issued the following statement after a White House meeting with CEOs of companies who have been involved in the effort to expand access to...
-
Mar 12, 2020
FRANKLIN LAKES, N.J. (March 12, 2019) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement: BD no longer manufactures or...
-
Mar 10, 2020CerTest Biotec launches CE Marked COVID-19 diagnostic test for the BD MAX™ System
CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 Real Time PCR Detection Kit...
-
Mar 9, 2020
FRANKLIN LAKES, N.J. (March 9, 2020) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on a previously announced voluntary...
-
Mar 2, 2020
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March...
-
Feb 27, 2020
SANTA BARBARA, Calif., Feb 27, 2020 -- Direct Relief, BD (Becton, Dickinson and Company) and the National Association of Free & Charitable Clinics (NAFC) today announced $125,000 in funding for...
-
Feb 20, 2020
FRANKLIN LAKES, N.J., February 20, 2020 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD Synapsys™ microbiology...
-
Feb 17, 2020BD Kiestra™ ReadA is device listed with the U.S. FDA
FRANKLIN LAKES, N.J., February 17, 2020 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the BD Kiestra™ ReadA is device...
-
Feb 13, 2020
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new, $6 million contract with the Fleming Fund, a U.K. aid program that helps low-...
-
Feb 12, 2020New capillary blood collection device combined with innovative sample handling and analytical technologies in clinical studies aim to make diagnostic blood testing more accessible and convenient
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and Babson Diagnostics, a transformative diagnostic blood testing company, today announced a long-term...
-
Feb 11, 2020
FRANKLIN LAKES, N.J. (Feb. 11, 2020) – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the completion of a 50-subject human clinical trial with...
-
Feb 6, 2020- As reported, revenues of $4.225 billion increased 1.6 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.225 billion for the first fiscal quarter ended December 31,...
-
Jan 29, 2020Three-year mortality and amputation data for Lutonix® 014 Drug-Coated Balloon Below-The-Knee IDE trial presented at LINC
FRANKLIN LAKES, N.J. (Jan. 29, 2020) – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced that interim findings from the Lutonix below-the-knee...
-
Jan 27, 2020
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.79 per common share, payable on March 31, 2020 to holders of record on March 10,...
-
Jan 23, 2020
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday,...